celastrol has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dai, M; Li, F; Rao, Q; Wu, ZE; Zhang, T; Zhao, Q | 1 |
Chen, X; Cheng, W; Ding, X; Liu, X; Wan, Y; Wu, L; Yang, B; Yang, N; Yu, S; Yu, X; Zhang, G; Zheng, J | 1 |
2 other study(ies) available for celastrol and Chemical and Drug Induced Liver Injury, Chronic
Article | Year |
---|---|
Tripterygium wilfordii protects against an animal model of autoimmune hepatitis.
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Concanavalin A; Hepatitis, Autoimmune; Mice; Models, Animal; Pentacyclic Triterpenes; Tripterygium; Triterpenes | 2023 |
Celastrol-loaded biomimetic nanodrug ameliorates APAP-induced liver injury through modulating macrophage polarization.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Biomimetics; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Humans; Liver; Liver Diseases; Macrophages; Mice; Mice, Inbred C57BL; Nanoparticles | 2023 |